Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of RANGAP1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of RANGAP1 mRNA | affects expression | 21346803
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RANGAP1 mRNA | decreases expression | 20018196 19150397
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of RANGAP1 mRNA | increases expression | 20106945
|
C014347 |
decitabine |
decitabine results in increased expression of RANGAP1 mRNA | increases expression | 17908484
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of RANGAP1 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of RANGAP1 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RANGAP1 mRNA | affects cotreatment|increases expression | 17942748
|
D019833 |
Genistein |
Genistein results in decreased expression of RANGAP1 mRNA | decreases expression | 16705744
|
D010126 |
Ozone |
Ozone results in increased expression of RANGAP1 mRNA | increases expression | 12763052
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of RANGAP1 mRNA | increases expression | 18301758
|
C009166 |
retinol acetate |
retinol acetate results in increased expression of RANGAP1 mRNA | increases expression | 16772331
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in increased expression of RANGAP1 mRNA | affects cotreatment|increases expression | 19244175
|
D012643 |
Selenium |
Selenium results in increased expression of RANGAP1 mRNA | increases expression | 19244175
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of RANGAP1 mRNA | decreases expression | 19822182
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of RANGAP1 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RANGAP1 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of RANGAP1 mRNA | increases expression | 17942748
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in increased expression of RANGAP1 mRNA | affects cotreatment|increases expression | 19244175
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of RANGAP1 mRNA | increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.61 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.90 | 15322242 14514962 11752688 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.00 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.15 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.38 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
4.38 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.07 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.07 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.76 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.96 | 17306315 16712894 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.44 | 15513908 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.51 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.68 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.56 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.64 | 17854713 16373670 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.86 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.86 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.78 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
1.96 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
1.96 | 16541309 16873071 17200150 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.96 | 19487384 11161223 19103187 20544844 18425577 18984771 17049068 19084267 20390343 16202921 15668708 18629630 16873071 16273361 17440819 16818667 21152245 19066611 19200415 19155303 19011961 19189212 21138602 18997820 19288272 19142967 17261762 19189210 20859285 19115204 19410462 18815881 19289846 20135344 19244106 19221464 18351453 15565566 20005174 17242785 18821012 18855134 20065188 19059307 17893378 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.96 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.70 | 18417511 17626835 18315731 15516495 19059883 16777450 14754758 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.79 | 16183385 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.97 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.55 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
8.93 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.93 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
8.93 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
8.93 | 17306315 16507464 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
8.93 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.82 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.82 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.64 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.38 | 18670907 16120746 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.32 | 16332659 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
16.18 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
16.18 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
16.18 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
16.18 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.47 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
13.47 | 15861022 11677210 16919318 17110522 17333356 16105132 17681005 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
13.47 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.11 | 16354765 15668235 12621046 15340226 8697196 |
MESH:D003092 |
Colitis |
|
Selenium |
3.82 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
3.90 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.90 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.49 | 20055451 15322242 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
2.49 | 19769572 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.04 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.04 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.40 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.44 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.35 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.35 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.50 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
9.04 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
9.04 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
9.04 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.04 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.78 | 11462148 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.77 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.63 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.63 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.96 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.07 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.07 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.18 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.64 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
7.59 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.59 | 16202921 20544844 19155303 17893378 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.05 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.08 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
18.99 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
18.99 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
18.99 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
18.99 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.25 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.58 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.23 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.62 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.62 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.73 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
3.28 | 16598420 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.50 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.62 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
6.62 | 16080930 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.01 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
7.01 | 17162251 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.40 | 19772884 16221962 19176532 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.40 | 12621046 15340226 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.71 | 16490937 16863852 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.18 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
4.03 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 16959395 16354765 18606429 8697196 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.21 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.98 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.98 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.85 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.49 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
11.34 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
11.34 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
11.34 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
4.93 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.93 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
11.17 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
11.17 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.65 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.36 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
10.18 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
10.18 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
10.18 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.91 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
17.95 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
17.95 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
17.95 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
17.95 | 18625569 |
MESH:D007938 |
Leukemia |
|
decitabine |
6.57 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.57 | 18980019 17468513 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.03 | 18454857 17236224 19117987 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.38 | 18460780 19387464 17679729 18704418 19010910 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.52 | 18055864 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.17 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
6.77 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.77 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
6.77 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.77 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
6.77 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
14.34 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
14.34 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
14.34 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
14.34 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.34 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
5.79 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.79 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
12.48 | 8266340 19066396 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
12.48 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
12.48 | 16863852 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.89 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
6.62 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.62 | 16712894 17077188 17306315 19931552 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
6.62 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.62 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
6.62 | 11062179 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.44 | 19470736 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.81 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
10.11 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
10.11 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
10.11 | 19196722 16827153 14580682 19196723 11731420 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.61 | 19453300 |
MESH:D008545 |
Melanoma |
|
decitabine |
5.16 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.16 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.16 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.23 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.80 | 15107826 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.17 | 10496685 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.36 | 18172295 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.55 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.40 | 18608210 19157545 19010910 16882708 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
5.71 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.71 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.04 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.46 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.46 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.52 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.52 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.55 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.52 | 19410462 |
MESH:D009369 |
Neoplasms |
|
decitabine |
8.35 | 17925555 19470736 19116145 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.35 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.35 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.71 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.06 | 19196722 19189210 19200415 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.31 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
9.73 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.73 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.16 | 12854658 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.82 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.98 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.98 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.27 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.12 | 16169203 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
8.02 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
8.02 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
8.02 | 17306315 15276417 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.77 | 19294695 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.72 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.17 | 16369182 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.95 | 15087411 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.44 | 18929643 18007984 18381685 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.25 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.24 | 11118676 11222880 11399792 11896295 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.77 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.08 | 16925846 15256057 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.08 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.08 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.08 | 15084515 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.36 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.40 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.43 | 19155313 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.93 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.93 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.45 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.63 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.63 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.77 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.77 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.09 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.82 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.54 | 16517955 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.65 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.18 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.35 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
15.92 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
15.92 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
15.92 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
15.92 | 11723127 16452187 16712894 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
15.92 | 17572228 8653321 16712894 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.16 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.16 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.79 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.33 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.98 | 17785578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.05 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.47 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.57 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |